Objective: Obesity is associated with multiple health problems and often originates in childhood. This study investigated the association of genes with the development of general and central obesity from childhood into adulthood. Design: Individual growth curves for measures of general adiposity were examined in an 11-year (1987-1998) cohort study. Single-nucleotide polymorphisms (SNPs) in 11 candidate genes were genotyped. Subjects: Five hundred and twenty-six subjects classified by race (49% African American (AA)), sex (47% male) and socioeconomic status (SES). Results: AA female carriers of the 27Glu allele in the ADRB2 gene had a larger waist circumference (Po0.05). Subjects of high SES with the ApoB 4145Lys allele had a larger mean waist circumference than those without this allele (Po0.05). Only in the presence of an adverse environment (low SES) did carriers of the NOS3 298Asp allele have a larger mean body mass index, waist circumference and sum of skinfolds (Po0.05). Conclusion: These results suggest that several polymorphisms are associated with the mean level of adiposity, with the effects depending on other factors such as race, sex and/or SES.
Introduction
Environmental and societal changes that promote calorie intake and discourage physical activity are generally held responsible for the recent obesity epidemic. Twin and family studies on the other hand, have indicated that at least half of the population variation in obesity can be explained by genetic factors. 1 These findings imply that an individual's response to 'obesogenic' environments is largely determined by genetic susceptibility. In short, the complex etiology of obesity reflects effects of genes and environment as well as their interactions. 2 The rise in overweight children and adolescents is of particular concern in the current obesity epidemic. 3, 4 The prevalence of overweight children in the United States (body mass index (BMI)495th percentile) has more than doubled since 1976 and currently exceeds 15%. 5 Because many overweight children go on to become obese adults, 6 greater insight into the development of adiposity from childhood into adulthood is needed. Several studies have confirmed the importance of genetic predisposition for obesity development in childhood. For example, Whitaker et al. 6 found that children (o10 years of age) of obese parents have a more than twofold increased risk of adult obesity. In another study, Bao et al. 7 observed that offspring of parents with a positive family history of coronary artery disease were consistently more overweight beginning in childhood. Crude indices of familial obesity risk as used in these studies do not provide information on the specific genes and physiological pathways that confer susceptibility to the development of obesity in youth. Although much effort has been and continues to be invested in finding genetic polymorphisms associated with obesity itself, 8 much less attention has been paid to finding genetic polymorphisms associated with the development of obesity. Only one study investigated the relationship between a candidate gene and longitudinal changes in adiposity from childhood to young adulthood. 9 However, this study did not include measures of central obesity, focused on just a single polymorphism and did not examine potential interactions with environmental determinants of obesity such as socioeconomic status (SES).
We have reported elsewhere the influence of race, sex and SES on development of general and central adiposity from childhood into adulthood in an 11-year cohort study of 622 African-American (AA) and European-American (EA) youth. 10 Two previous studies of the same cohort 11, 12 showed that general adiposity was the most important predictor of systolic blood pressure and left ventricular mass development across a 10-year period, suggesting that obese children are at higher risk of developing hypertension and left ventricular hypertrophy as adults. These findings help to illustrate the pivotal role that juvenile obesity prevention could play in managing and controlling cardiovascular disease (CVD) risk in adulthood. Identification of genetic factors conferring susceptibility to obesity could help target prevention efforts to the most vulnerable individuals to yield the highest benefit. In this study, we investigated the influence of one singlenucleotide polymorphism (SNP) from each of 11 different candidate genes involved in energy intake, energy expenditure and adipogenesis on development of general and central adiposity in the same cohort. Ten of these SNPs were selected based on the likelihood of functional involvement in physiological pathways underlying the development of obesity and replication in the literature as reported in the Human Obesity Gene Map. 8 An additional SNP in the endothelial nitric oxide synthase (NOS3) gene was selected based on evidence that NO production inhibits adipose tissue lipolysis in obesity. 13, 14 We further examined whether effects of these polymorphisms on growth curves were moderated by race, sex and SES. On the baseline evaluation, subjects were apparently healthy based on parental report of the child's medical history. Subjects were classified as AA or EA according to criteria described previously. 18 Informed consent was obtained from one of the parents and informed assent from the child in accordance with procedures approved by the Institutional Review Board at the Medical College of Georgia. BMI (weight/height 2 ), waist circumference and sum of three skinfolds (subscapular, suprailiac and triceps) were measured at each annual laboratory visit during an 11-year period as described in Dekkers et al. 10 BMI and sum of skinfolds were used as measures of general adiposity, whereas waist circumference was used as the measure of central adiposity.
Methods

Subjects
19
SES was represented by father's education level, because this measure remained highly stable across the years of the study and was the only measure of SES for which adiposity growth curves differed in our previous study. 10 Father's education level was divided into three categories: low education level (o12 years), medium education level (X12 and o16 years) and high education level (X16 years).
Genotyping DNA was extracted from plasma buffy coats or buccal swabs by using the QiaAmp DNA Blood Mini Kit (Qiagen, Valencia, CA, USA) or QuickExtract DNA extraction Kit (Epicentre, Madison, WI, USA). All polymorphisms were detected by polymerase chain reaction with restriction-fragment length polymorphism (PCR-RFLP), as previously described elsewhere (see Table 1 for references) with minor modifications. Random replicate samples, up to 10% of the samples, were also confirmed by direct sequence analysis with the use of a Bigdye terminator kit on an ABI-377 automated sequencer. Genotyping was carried out in batches and each batch contained appropriate and verified allelic controls. The estimated genotyping error rate was approximately 2%. To prevent observer bias, the investigators were unaware of sample origin and all gels were cross-checked by a separate investigator. . Our approach is to simultaneously model race, sex and SES as factors in our models for three reasons: this approach is more powerful than subgroup analyses; this approach allowed us to statistically test for gender-, ethnic-and SES-specific effects of the SNPs on slope and level of the growth curves; and this approach allows us to statistically control for confounding such as that between race and SES. We did compare frequencies of subjects across race, sex and SES categories using log-linear models, finding that the frequency of subjects in the three SES categories differed between races (P ¼ 0.0001) with the high SES being overrepresented and low SES underrepresented in white subjects. This association between SES and race is the sort of confounding that could lead to spurious association had SES not been included in the analyses.
Statistical analyses
On the basis of our earlier results, we used a base model that included all interactions involving race, gender and SES, and added the two-way interactions of SNP genotype or FH were also included, but no other higher-order interactions were included owing to small cell sizes. For each adiposity measure, we analyzed 11 mixed linear models, one for each SNP. The effect of each SNP was included in our models as multiple parameters representing main effects and interactions.
As such, we first tested the overall gene effect using a likelihood ratio test (LRT) comparing models with and without all terms involving SNPs. Because most SNPs had rare alleles, we combined the rare homozygote with the heterozygote for analyses of these SNPs (all except GNB3 and LEPR). This difference in the way that SNPs are handled in the analyses results in the degrees of freedom for the overall SNP test to vary between the SNPs. We then adjusted for multiple testing using the false discovery rate (FDR) approach of Benjamini and Hochberg, 32 which controls the expected proportion of false positives among the set of significant findings. Because the adiposity measures in this study were correlated, we used a separate FDR correction for each adiposity measure. Using this approach, we identified the SNPs that had overall effects, and subsequently examined all gene effects separately for the 'discovered' SNPs using standard hypothesis testing. The analysis of individual growth curves was implemented using mixed linear models in Proc Mixed of the SAS/Stat software package (Release 8.02, 1999, SAS Institute Inc., Cary, NC, USA). Subjects were omitted from analyses for one of two reasons. First, the subject recruitment included sibs, and accounting for the correlation structure between sibs in this analysis was not computationally possible, especially because the percentage of subjects that were sibs was small. As such, we only included the first recruited sib in all analyses. Further, only subjects with at least three observations were included because the analyses depend on fitting polynomial regression curves to each subject's data. Five hundred and twenty-six (526) subjects (113 AA male, 146 AA female, 136 EA male and 131 EA female subjects) met these criteria, although DNA (and SNP genotype) was not available for all of these subjects ( Table 2 ). The study design is complicated because not all subjects had the same number of visits, with subjects recruited into the study at different ages and different years. However, more than 80% of the 526 subjects had at least five visits, making this dataset very informative for the study of adiposity changes over time. 10 Further, our use of growth curve modeling and the Proc Mixed procedure in SAS is 
Genetic associations
Most of the SNPs were found to have frequencies in HardyWeinberg proportions within each race, but many of the frequencies for the SNPs differed between the races (Table 2) . Only ADRB3 frequencies for both races and GNB3 for EAs were not in Hardy-Weinberg equilibrium. Using a 5% FDR, only two SNPs showed a significant relationship with an adiposity measure (Table 3) : APOB with waist circumference and NOS3 with BMI. Two relationships had expected FDRs that were close to 5%: ADRB2 and GNB3 with waist circumference. Three relationships also had FDRs that were approximately 7%: NOS3 with waist circumference and sum of skinfolds and GNB3 with sum of skinfolds. We decided to examine further the results for all of these relationships because an FDR of 8% would be expected to result in only 0.56 (8% of 7) false discoveries when only seven tests are called significant.
The ADRB2 SNP showed only one significant effect, an interaction with both race and sex for waist circumference (P ¼ 0.042). AA female subjects with the ADRB2 allele coding for Glu had a larger mean waist circumference (81.5 cm, 95% CI: 76.9, 86.9) than AA female subjects without the allele (76.0 cm, 95% CI: 72.7, 79.4; P ¼ 0.04), but this relationship was not seen in male subjects or EA female subjects.
Although the ApoB SNP had the smallest P-value, only one of the effects involving the SNP was significant at the 0.05 level, the higher-order interaction between ApoB, race, sex and age 3 (P ¼ 0.01). The effect with the next smallest P-value was the interaction between ApoB and SES (P ¼ 0.07). 
4).
All measures of adiposity showed some relationship with NOS3 (Table 3) . Differences in the mean of all adiposity measures depended on both the NOS3 SNP and SES (Po0.05 for all interactions). The mean of all three adiposity measures was much larger for subjects of low SES carrying the 298Asp allele than for those of low SES without the 298Asp allele, but these differences were not observed in subjects of mid to high SES (Figure 1) . The NOS3 SNP also showed an interaction with race in affecting the slope of BMI growth curves (Po0.05), with the slope increasing in AA and decreasing in EA. However, the differences in the means that result from these differences in slope were small relative to the differences in mean due to the interaction with SES. The NOS3 SNP also showed an interaction with SES in relation to the slope of the growth curves for waist circumference (P ¼ 0.01, 0.34 and 0.04 for age, age 2 Genes and adiposity growth curves in youth RH Podolsky et al age 3 , respectively; Figure 2) , with the slope for the linear component increasing at low SES and showing no difference between genotypes for mid and high SES. Likewise, the NOS3 SNP showed an interaction with SES in relation to the slope of the growth curve for sum of skinfolds (P ¼ 0.05 for age), but this time the low SES group showed no difference in slope while the other two SES groups showed some difference. However, the differences in means that would result from these interactions for the slopes of both waist circumference and sum of skinfold growth curves were again small relative to the differences in means due to the interaction of NOS3 and SES.
Discussion
This study investigated the influence of SNPs in 11 different candidate genes involved in energy intake, energy expenditure and adipogenesis on growth curves for adiposity in AA and EA youth. We observed effects of four SNPs on levels of growth curves, with effects on the slope of the growth curves being small relative to the effects on mean levels for all adiposity measures. These results corroborate and extend the evidence listed in the Human Obesity Gene Map 8 to the involvement of SNPs in ADRB2, ApoB and GNB3 in the development of obesity. The fourth SNP (Glu298Asp in NOS3), selected based on evidence that NO production inhibits adipose tissue lipolysis in obesity, 13, 14 showed an interaction with SES (that is, a gene-environment interaction). Only in the presence of an adverse environment (that is, low SES) did carriers of this polymorphism show larger means for all three adiposity measures. Several studies have now reported on candidate gene associations with weight gain. Two of these studies have examined weight gain in which weight was measured only twice (for example, van Rossum et al. 33, 34 ). Three studies have examined candidate gene associations with weight gain in longitudinal studies with adiposity measured over several years, 9, 35, 36 all of which focus on b-adrenergic receptors. The
Bogalusa Heart study 9 has found suggestive evidence for increased weight gain from childhood to young adulthood in male carriers of the Gly allele of the ADRB2 Arg16Gly polymorphism, and this increase in weight gain is potentially dependent on b1-adrenergic receptor genotype. 35 Masuo et al. 36 also examined longitudinal changes in weight gain over a 5-year period in young Japanese men, finding that Gly16 allele of the Arg16Gly in the b2-adrenergic receptor was associated with increased weight gain. The longitudinal nature of these studies and ours has several advantages. First, it has allowed us to examine the entire transitional period from childhood to adulthood. This time period is critical because overweight children often go on to become obese adults. 6 We were also able to test for effects on overall adiposity level and on the rate of change in adiposity levels during this period. Unfortunately, we only found limited evidence of SNPs being associated with a more rapid increase in adiposity measures alone, or moderated by race, sex and/or SES. The differences in means resulting from the slope effects that we did observe were small relative to effects that did not involve the slope (that is, effects on the level of the growth curves). Second, this design is expected to have superior power to detect effects on adiposity levels compared to cross-sectional candidate gene studies, because measurement of subjects at multiple time points provides much better precision in determining their typical adiposity phenotype. [37] [38] [39] [40] As such, longitudinal studies such as this one require a fraction of the sample size of cross-sectional candidate gene studies to achieve the same power.
In this study, we only selected SNPs with a high likelihood of functional involvement in physiological pathways underlying the development of obesity. 8 Still, the majority of the SNPs we examined did not show any relationship with the development of obesity in AA or EA youth. We conducted some power analyses to examine the power we had for a few Genes and adiposity growth curves in youth RH Podolsky et al
of the SNPs that were tested (NOS3, ADRB2 and LEPR) based on a cross-sectional study for only one race. The number of subjects we included in our study provided 80% power to detect an effect that accounts for approximately 3% of the variation for NOS3 and ADRB2, whereas our study had 80% power to detect an effect that accounts for approximately 5% of the variation for LEPR. Because we analyzed both races together, our power will be even better. Further, the longitudinal nature of our study was expected to provide our study with the equivalent power of a cross-sectional study with many times more subjects, 37, 38 indicating that insufficient power was unlikely to be the main reason for the lack of significant findings. A more compelling explanation is that general and central adiposity are complex phenotypes with contribution of any single SNP likely to be small. Furthermore, the development of obesity takes place over many years and effects could be limited to the age range of the subjects in any particular study. Several studies have provided evidence for two important transitional periods, one at around 20 years and one at about 50 years. 41, 42 Fabsitz et al. 41 found small genetic correlations between these ages suggesting that different genes are involved in these two transition periods. These results imply that effects of some adiposity genes are likely to be age-specific. For example, the case-control association study of Corbalán et al. 43 found the largest effect of the ADRB3 mutation in individuals who were 20-35 years. As our study had relatively few measurements for subjects in early adulthood, we might have been unable to detect any effects of genes that are mainly expressed beyond the ages we examined.
The sampling of our study may also affect our conclusions because most participants of our study had a verified positive family history of CVD (either EH or MI), and female subjects with a FH þ of EH were found to have larger mean BMI and waist circumference than those with a FH À of EH. This oversampling can either increase or decrease power depending on the specific gene, with the effect being mediated through gene frequencies. Thus, any effect of oversampling would likely be evident as differences in allele frequencies between our sample and a random sample. However, the allele frequencies that we observed were similar to those found in other studies (Table 1) . Additionally, comparison of these subjects with a similarly aged cohort of unselected youth 20 revealed no differences in blood pressure. 44 These two observations, similar allele frequencies combined with a lack of difference in blood pressure, suggest it is unlikely that our oversampling of subjects with FH þ of CVD has affected the extent to which our results apply to the general population.
The results involving the NOS3 SNP are noteworthy because we provide evidence for a gene by SES interaction. Only in the presence of an adverse environment did carriers express a negative effect on adiposity growth curves. Our SES measure may represent a cumulative index of unhealthy lifestyle habits such as high-fat diets, low levels of physical activity and exposure to chronic stress, which may have enabled the detection of the interaction effect. However, we cannot determine which specific components may be interacting with this SNP in affecting adiposity. We are unaware of any studies that have examined interactions between diet or physical activity with the NOS3 gene in its effect on adiposity, but some studies have investigated the influence of physical activity levels and/or diet for ADRB2, 45 ,46 ADRB3 47 and GNB3, 48 finding associations only in sedentary subjects 45, 47, 48 or only in subjects with a high carbohydrate intake. 46 We also found an interaction between the GNB3 SNP and SES in the current study, but the pattern was difficult to interpret. This SNP was one of two not in Hardy-Weinberg frequencies for EAs. We do not expect that deviations from Hardy-Weinberg frequencies would lead to a false association with regard to changes in slope in a longitudinal study because that analysis associates observed changes in adiposity with SNP genotype. However, because the observed association for the GNB3 SNP was with mean levels, the deviation from Hardy-Weinberg frequencies in one population and not the other could be the explanation for our peculiar findings for the GNB3 SNP. Our use of the FDR as the overall adjustment for multiple testing may also be one explanation for the strange findings for the GNB3 SNP. Our expectation that only 0.56 false discoveries would be expected for seven tests using an 8% FDR assumed that the tests for each adiposity measure were independent, which is clearly not true. One approach to handling this lack of independence would be to use bootstraps or permutations to evaluate the FDR across the entire set of tests. This approach is limiting in this case because the computational time that would be required for each bootstrap replicate would be exceedingly long. We did calculate FDR q-values for the overall gene test using the entire set of tests for all adiposity measures, assuming the tests were independent. The q-values obtained using this procedure were similar to those observed using the FDR adjustment separately for each adiposity measure. All q-values for the relationships between genes and adiposity measures that we examined were still below 0.08, with the exception of the test for the relationship between NOS3 and waist circumference which was 0.1231. Interestingly, the q-value for the relationship between the PPARG SNP and BMI decreased to 0.12, the same as observed for the relationship between NOS3 and waist circumference. These results suggest that the true FDR could be as large as 12-13%, which would result in less than one expected false discovery among seven tests. Which one result is due to a false discovery cannot be determined here, but one possibility is that the results for the GNB3 SNP represent a false discovery. Regardless, the results for all SNPs should be confirmed with additional studies.
In summary, we confirmed the association of several SNPs in a number of established candidate genes with the development of obesity in youth, but the effects of these SNPs on the mean level of adiposity were often dependent on race, sex and/or SES. We also found evidence of a geneenvironment interaction involving SES and the NOS3 gene, which is not yet recognized as an established candidate gene for obesity. Further refinement of measures of the environment (diet and physical activity) as well as the genes (measurement of multiple SNPs within the same genes to perform haplotype analyses) will optimize chances of future longitudinal candidate gene studies providing insight in the complex etiology of obesity development at different periods of the life span.
